Literature DB >> 24123979

Cord blood levels of osteopontin as a phenotype marker of gestational age and neonatal morbidities.

Kyoung Eun Joung1, Helen Christou, Kyung-Hee Park, Christos S Mantzoros.   

Abstract

OBJECTIVES: Osteopontin (OPN) is a proinflammatory cytokine associated with metabolic syndrome. Extreme birth weight categories including small for gestational age (SGA), and large for gestational age (LGA) are risk factors for metabolic syndrome. However normal levels of plasma OPN in neonates and the relationship of OPN to fetal growth remain unknown. We evaluated the association of umbilical cord blood OPN with gestational age, birth weight, and neonatal outcomes.
METHODS: A cross-sectional study of 261 newborns of all gestational ages beginning at week 26, and 26 adults for comparison was performed. Umbilical cord blood from newborns and analyzed plasma for OPN by ELISA was collected.
RESULTS: Plasma OPN was significantly higher in neonates (414.65 ± 136.72 ng/mL) compared to adults (33.37 ± 14.66 ng/mL, P < 0.001). There was an inverse correlation between OPN and gestational age (r = -0.48, P < 0.0001). LGA infants had lower OPN than appropriate for gestational age (AGA) infants, but LGA was not an independent predictor of OPN in multivariate analysis. Among preterm infants, patent ductus arteriosus (PDA) was independently associated with higher OPN (OR = 2.49, P = 0.02).
CONCLUSION: Our results raise the possibility that OPN has a physiologic role in fetal growth and development, and may be a useful biomarker for PDA.
Copyright © 2013 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24123979      PMCID: PMC4394598          DOI: 10.1002/oby.20626

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  25 in total

1.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

Review 2.  Progress in pathogenesis and management of clinical intraamniotic infection.

Authors:  R S Gibbs; P Duff
Journal:  Am J Obstet Gynecol       Date:  1991-05       Impact factor: 8.661

Review 3.  Developmental origins of adult disease.

Authors:  Rebecca A Simmons
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

4.  Criteria for screening tests for gestational diabetes.

Authors:  M W Carpenter; D R Coustan
Journal:  Am J Obstet Gynecol       Date:  1982-12-01       Impact factor: 8.661

5.  Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.

Authors:  Guangwu Xu; Hong Nie; Ningli Li; Wenxin Zheng; Dongqing Zhang; Guozhang Feng; Liqing Ni; Rong Xu; Jian Hong; Jingwu Z Zhang
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

6.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

Authors:  A Oldberg; A Franzén; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 7.  Molecular mechanisms of vitamin D action.

Authors:  Mark R Haussler; G Kerr Whitfield; Ichiro Kaneko; Carol A Haussler; David Hsieh; Jui-Cheng Hsieh; Peter W Jurutka
Journal:  Calcif Tissue Int       Date:  2012-07-11       Impact factor: 4.333

8.  Regulation of bone sialoprotein and osteopontin mRNA expression by dexamethasone and 1,25-dihydroxyvitamin D3 in rat bone organ cultures.

Authors:  J Chen; H F Thomas; J Sodek
Journal:  Connect Tissue Res       Date:  1996       Impact factor: 3.417

Review 9.  Osteopontin: roles in implantation and placentation.

Authors:  Greg A Johnson; Robert C Burghardt; Fuller W Bazer; Thomas E Spencer
Journal:  Biol Reprod       Date:  2003-07-30       Impact factor: 4.285

10.  A nearly continuous measure of birth weight for gestational age using a United States national reference.

Authors:  Emily Oken; Ken P Kleinman; Janet Rich-Edwards; Matthew W Gillman
Journal:  BMC Pediatr       Date:  2003-07-08       Impact factor: 2.125

View more
  4 in total

Review 1.  Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants.

Authors:  Hans Demmelmair; Christine Prell; Niklas Timby; Bo Lönnerdal
Journal:  Nutrients       Date:  2017-07-28       Impact factor: 5.717

2.  Osteopontin and malaria: no direct effect on parasite growth, but correlation with P. falciparum-specific B cells and BAFF in a malaria endemic area.

Authors:  Susanne E Mortazavi; Allan Lugaajju; Mark Kaddumukasa; Muyideen Kolapo Tijani; Fred Kironde; Kristina E M Persson
Journal:  BMC Microbiol       Date:  2021-11-06       Impact factor: 3.605

3.  The Patent Ductus Arteriosus in Extremely Preterm Neonates Is More than a Hemodynamic Challenge: New Molecular Insights.

Authors:  Anna Sellmer; Tine Brink Henriksen; Johan Palmfeldt; Bodil Hammer Bech; Julie Astono; Tue Bjerg Bennike; Vibeke Elisabeth Hjortdal
Journal:  Biomolecules       Date:  2022-08-25

4.  Cord blood adiponectin and leptin are associated with a lower risk of stunting during infancy.

Authors:  Sangshin Park; Zorimel Vargas; Anne Zhao; Palmera I Baltazar; Jennifer F Friedman; Emily A McDonald
Journal:  Sci Rep       Date:  2022-09-06       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.